NewLink Genetics to Participate in the Jefferies 2018 Global Healthcare Conference
May 30 2018 - 9:00AM
NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the
company will present at the Jefferies 2018 Global Healthcare
Conference on Thursday, June 7, 2018, at 8:00AM ET.
A live webcast of the presentation will be available on the
Company’s website at www.newlinkgenetics.com in the “Investors
& Media” section under “Events and Presentations.” An
archived edition of the presentation will be available on the
Company’s website later in the day.
About NewLink Genetics Corporation
NewLink Genetics is a clinical-stage
biopharmaceutical company focused on discovering, developing and
commercializing novel immuno-oncology product candidates to improve
the lives of patients with cancer. NewLink Genetics' leading drug
candidate, indoximod, is an investigational, orally available small
molecule designed to harness multiple components of the immune
system to combat cancer. For more information, please
visit www.newlinkgenetics.com and follow us on Twitter
@NLNKGenetics.
Investor Contact:
Lisa MillerDirector of Investor RelationsNewLink
Genetics515-598-2555lmiller@linkp.com
Media Contact:
Sharon CorreiaVP, Integrated
CommunicationsLaVoieHealthScience617-374-8800, ext.
105scorreia@lavoiehealthscience.com
NewLink Genetics (NASDAQ:NLNK)
Historical Stock Chart
From Aug 2024 to Sep 2024
NewLink Genetics (NASDAQ:NLNK)
Historical Stock Chart
From Sep 2023 to Sep 2024